Earnings season is now well under way, with a number of major companies due to release results in the coming week. Investors ...
A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans at risk for kidney failure.
Organization highlights transformative approaches to clinical research, operational efficiency and patient-centric care at SCOPE US 2025 PH ...